Concomitant Chemoradiotherapy With Mitomycin C and Cisplatin in Advanced Unresectable Carcinoma of the Head and Neck: Phase I-II Clinical Study

Article ID	Journal	Published Year	Pages	File Type
8237369	International Journal of Radiation OncologyBiologyPhysics	2008	8 Pages	PDF

Abstract

Concomitant chemoradiotherapy with mitomycin C and cisplatin “chemoboost” at 14 mg/m2/d is feasible, with encouraging survival results if the extremely poor disease profile of the treated patients is considered.

Keywords

Head and neck cancer Concomitant chemoradiotherapy Clinical trial Squamous cell carcinoma

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Concomitant Chemoradiotherapy With Mitomycin C and Cisplatin in Advanced Unresectable Carcinoma of the Head and Neck: Phase I-II Clinical Study

Authors

PrimoÅ¾ M.D., Ph.D., Katarina M.D., M.Sc., Lojze M.D., Ph.D., Erika M.D., Ph.D., Igor M.D., Ph.D., Boris M.D., M.Sc., Aleksandar M.D., M.Sc., Marjan M.D., Ph.D., Branko M.D., Ph.D.,